Oseltamivir labels and packages

Revision as of 15:35, 8 January 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Oseltamivir}} {{CMG}}; {{AE}} {{SS}} ==Labels And Packages== {| |- |thumb|1600px|left |- |} {| |- |File:Oseltamivir 9.jpg|thumb|1600p...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Oseltamivir
TAMIFLU® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Labels And Packages

[1]

References

  1. "TAMIFLU (OSELTAMIVIR PHOSPHATE) POWDER, FOR SUSPENSION TAMIFLU (OSELTAMIVIR PHOSPHATE) CAPSULE [GENENTECH, INC.]". Retrieved 8 January 2014.

Adapted from the FDA Package Insert.